Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021

被引:3
|
作者
Felzer, Jamie R. [1 ]
Montgomery, Amy J. [2 ]
Lemahieu, Allison M. [3 ]
Rutten, Lila J. Finney [4 ]
Juhn, Young J. [5 ,6 ]
Wi, Chung-Il [5 ,6 ]
Jacobson, Robert M. [4 ,5 ,6 ,7 ]
Kennedy, Cassie C. [1 ,8 ,9 ]
机构
[1] Mayo Clin, Div Pulm & Crit Care, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Med, Rochester, MN USA
[3] Mayo Clin, Div Clin Trials & Biostat, Rochester, MN USA
[4] Mayo Clin, Div Epidemiol, Rochester, MN USA
[5] Mayo Clin, Dept Quantitat Hlth Sci, Div Community Pediat Med, Rochester, MN USA
[6] Mayo Clin, Dept Quantitat Hlth Sci, Div Adolescent Med, Rochester, MN USA
[7] Mayo Clin, Div Pediat Infect Dis, Rochester, MN USA
[8] Mayo Clin, Dept Pediat & Adolescent Med, Div Hlth Care Delivery Res, Rochester, MN 55905 USA
[9] Mayo Clin, Resp Hlth Equ Clin Res Lab, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
adult; health care disparities; respiratory tract infections; risk factors; sociodemographic factors; vaccines; MEDICAL-RECORDS-LINKAGE; DATA RESOURCE PROFILE; ADVISORY-COMMITTEE; CONJUGATE VACCINE; UNITED-STATES; SOCIOECONOMIC-STATUS; UPDATED RECOMMENDATIONS; POLYSACCHARIDE VACCINE; DISEASE; HEALTH;
D O I
10.1016/j.chest.2024.01.049
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Despite effective vaccines against in fl uenza, pneumococcus, and COVID-19, uptake has been suboptimal. RESEARCH QUESTION: Although disparities in vaccination by race and ethnicity have been observed, what is the role of other sociodemographic factors in US vaccine uptake? STUDY DESIGN AND METHODS: We conducted a population-based study using the Rochester Epidemiology Project (REP), a comprehensive medical records linkage system, to assess effects of sociodemographic factors including race, ethnicity, individual-level socioeconomic status (SES) via the housing-based socioeconomic status index, education, population density (urban or nonurban), and marital status with uptake of in fl uenza, pneumococcal, and COVID-19 vaccination in high-risk adults. Adults at high risk of invasive pneumococcal disease residing in four counties in southeastern Minnesota who were aged 19 to 64 years were identi fi ed. Vaccination data were obtained from the Minnesota Immunization Information Connection and REP from January 1, 2010, through December 31, 2021. RESULTS: We identi fi ed 45,755 residents. Most were White (82%), non-Hispanic (94%), married (56%), and living in an urban setting (81%), with three-quarters obtaining at least some college education (74%). Although 45.1% were up to date on pneumococcal vaccines, 60.1% had completed the primary COVID-19 series. For in fl uenza and COVID-19, higher SES, living in an urban setting, older age, and higher education positively correlated with vaccination. Magnitude of differences in race, education, and SES widened with booster vaccines. INTERPRETATION: This high-risk population is undervaccinated against preventable respiratory diseases, especially in fl uenza and pneumococcus. Although national data reported improvement of disparities in COVID-19 vaccination uptake observed early in the pandemic, our data demonstrated gaps related to race, education level, SES, and age that widened with booster vaccines. Communities with high social vulnerabilities often show increased risk of severe disease outcomes, yet demonstrate lower uptake of preventive services. This highlights the need to understand better vaccine compliance and access in rural, lower SES, lesseducated, Black, Hispanic, and younger populations, each of which were associated independently with decreased vaccination. CHEST 2024; 166(1):49-60
引用
收藏
页码:49 / 60
页数:12
相关论文
共 50 条
  • [41] Axillary lymphadenopathy in a high-risk breast screening patient following the COVID-19 vaccine: a diagnostic conundrum
    Musaddaq, Besma
    Brown, Adam
    Dluzewski, Sam
    Marafioti, Teresa
    Malhotra, Anmol
    BJR CASE REPORTS, 2021, 7 (06):
  • [42] COVID-19's Impact on Willingness to Be Vaccinated against Influenza and COVID-19 during the 2020/2021 Season: Results from an Online Survey of Canadian Adults 50 Years and Older
    Waite, Nancy M.
    Pereira, Jennifer A.
    Houle, Sherilyn K. D.
    Gilca, Vladimir
    Andrew, Melissa K.
    VACCINES, 2021, 9 (04)
  • [43] Successful delivery of mRNA COVID-19 vaccine to high-risk children aged 12+with a history of immediate reaction to polyethylene glycol (PEG)
    Cloonan, Jeanne
    Crealey, Miranda
    Whooley, Paul
    Alsaleemi, Ali
    Fitzpatrick, Maura
    Evans, Pamela
    Malone, Andrea
    O'Marcaigh, Aengus
    Kelleher, Maeve
    Byrne, Aideen
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (08): : 1054 - 1055
  • [44] Effect of influenza vaccine subsidies for older adults on vaccination coverage and mortality before and during the COVID-19 pandemic: an ecological study in Japan
    Ando, T.
    Ibuka, Y.
    Goto, R.
    Haruta, J.
    Le, D. D.
    Fujishima, S.
    PUBLIC HEALTH, 2023, 224 : 152 - 158
  • [45] RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022
    Haeberer, Mariana
    Mengel, Martin
    Fan, Rong
    Toquero-Asensio, Marina
    Martin-Toribio, Alejandro
    Liu, Qing
    He, Yongzheng
    Uppal, Sonal
    Rojo-Rello, Silvia
    Dominguez-Gil, Marta
    Hernan-Garcia, Cristina
    Fernandez-Espinilla, Virginia
    Liang, Caihua
    Begier, Elizabeth
    Castrodeza Sanz, Javier
    Eiros, Jose M.
    Sanz-Munoz, Ivan
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (09) : 1983 - 1999
  • [46] COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years-United States, November 2021-January 2022
    Kim, Christine
    Yee, Randy
    Bhatkoti, Roma
    Carranza, David
    Henderson, Danielle
    Kuwabara, Sachiko A.
    Trinidad, James Philip
    Radesky, Sandra
    Cohen, Allen
    Vogt, Tam M.
    Smith, Zachary
    Duggar, Chris
    Chatham-Stephens, Kevin
    Ottis, Christina
    Rand, Krista
    Lim, Travis
    Jackson, Alice F.
    Richardson, Donald
    Jaffe, Aaron
    Lubitz, Rachael
    Hayes, Ryan
    Zouela, Aran
    Kotulich, Deborah L.
    Kelleher, Patrick N.
    Guo, Angela
    Pillai, Satish K.
    Patel, Anita
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (10): : 378 - 383
  • [47] Interprofessional student-led outreach to high-risk older adults during the COVID-19 pandemic
    Martinez, Desirae J.
    Hamamsy, Karima C.
    Hines, Susan E.
    Daddato, Andrea E.
    Pearson, Scott M.
    Lum, Hillary D.
    Hardland, Janna
    Church, Skotti D.
    Tietz, Sarah E.
    GERONTOLOGY & GERIATRICS EDUCATION, 2022, 43 (01) : 34 - 42
  • [48] Barriers to influenza vaccination among African American older adults and persons aged 18-64 years with high-risk medical conditions
    Ohuabunwa, U. K.
    Safran, E.
    Ohuabunwa, C.
    Mensah, E.
    Henriques, M.
    Akomolafe, A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 20 - 20
  • [49] In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose
    Chagla, Zain
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (03) : JC28 - JC28
  • [50] The Impact of a COVID-19 Positive Diagnosis on the Risk of Polypharmacy on Contmunity-Dwelling Adults Aged 65 Years and Older
    Lang, A.
    Gurvich, T.
    Sehgal, S.
    Gibbs, L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S297 - S297